Product information and disease descriptionPlace of product in therapyDisease description
Long-term morbidity
26 evidence topics · 12 sources
Psoriatic arthritis: incidence and risk factors in a prospective cohort
“The data obtained from the 464 patients who were followed up for 8 years were analyzed. A total of 51 patients developed PsA during the 8 years since enrollment. The annual incidence rate of PsA was 2.7 cases (95% confidence interval 2.1-3.6) per 100 psoriasis patients.” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
“A severe psoriasis phenotype, presence of nail pitting, low level of education, and uveitis are predictive of the development of PsA in patients with psoriasis.” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
Psoriatic arthritis: pooled prevalence, 266 studies
“A total of 266 studies examining 976,408 patients with psoriasis were included. Overall, the pooled proportion (95% confidence interval [CI]) of PsA among patients with psoriasis was 19.7% (95% CI, 18.5%-20.9%).” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
“The PsA prevalence was 22.7% (95% CI, 20.6%-25.0%) in European patients with psoriasis, 21.5% (95% CI, 15.4%-28.2%) in South American patients with psoriasis, 19.5% (95% CI, 17.1%-22.1%) in North American patients with psoriasis” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
“The incidence of PsA among patients with psoriasis ranged from 0.27 to 2.7 per 100 person-years.” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
Psoriatic arthritis: onset after skin disease
Myocardial infarction risk by severity and age
“The incidences per 1000 person-years for control patients and patients with mild and severe psoriasis were 3.58 (95% confidence interval [CI], 3.52-3.65), 4.04 (95% CI, 3.88-4.21), and 5.13 (95% CI, 4.22-6.17), respectively.” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
“For example, for a 30-year-old patient with mild or severe psoriasis, the adjusted RR of having an MI is 1.29 (95% CI, 1.14-1.46) and 3.10 (95% CI, 1.98-4.86), respectively. For a 60-year-old patient with mild or severe psoriasis, the adjusted RR of having an MI is 1.08 (95% CI, 1.03-1.13) and 1.36 (95% CI, 1.13-1.64), respectively.” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
Major adverse cardiovascular events: meta-analysis of nine studies
“Severe psoriasis was associated with a significantly increased risk of cardiovascular mortality (RR, 1.39; 95% CI, 1.11 to 1.74), myocardial infarction (RR, 1.70; 95% CI, 1.32 to 2.18), and stroke (RR, 1.56 95% CI, 1.32 to 1.84).” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Based on these risk ratios and the background population event rates, psoriasis is associated with an estimated excess of 11 500 (95% CI, 1169 to 24 407) major adverse cardiovascular events each year.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
Diabetes: prevalence and incidence meta-analysis
“Among studies assessing the prevalence, psoriasis was associated with an odds ratio (OR) of 1.59 (95% CI, 1.38-1.83) for diabetes. The pooled OR was 1.53 (95% CI, 1.16-2.04) for mild psoriasis and 1.97 (1.48-2.62) for severe psoriasis.” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
“Among studies that assessed incidence, psoriasis was associated with a relative risk of 1.27 (95% CI, 1.16-1.40) for developing diabetes.” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
Metabolic syndrome: pooled odds ratio and dose-response relationship
“Based on random-effects modeling of cross-sectional and case-controlled studies, the pooled odds ratio (OR) for metabolic syndrome among patients with psoriasis was 2.26 (95% confidence interval [CI] 1.70-3.01) compared with the general population.” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
“A dose-response relationship was also observed between psoriasis severity and prevalence of metabolic syndrome.” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
Non-alcoholic fatty liver disease: meta-analysis in chronic plaque psoriasis
“We identified 15 observational (case–control and cross-sectional) studies for a total of 249,933 patients with psoriasis (49% with NAFLD) and 1,491,402 controls (36% with NAFLD). Psoriasis was associated with prevalent NAFLD (n = 11 studies; pooled random-effects odds ratio [OR] 1.96, 95% CI 1.70–2.26; I2 = 97%, p < 0.01).” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
Inflammatory bowel disease: meta-analysis
“Significant associations were found between psoriasis and Crohn disease (odds ratio, 1.70; 95% CI, 1.20-2.40) and between psoriasis and ulcerative colitis (odds ratio, 1.75; 95% CI, 1.49-2.05). Patients with psoriasis had an increased risk of Crohn disease (risk ratio, 2.53; 95% CI, 1.65-3.89) and ulcerative colitis (risk ratio, 1.71; 95% CI, 1.55-1.89).” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
Depression: prevalence and odds meta-analysis
“The prevalence of depressive symptoms was 28% using questionnaires and the prevalence of clinical depression was 12% using International Classification of Diseases codes, 19% using Diagnostic and Statistical Manual of Mental Disorders IV, and 9% for antidepressant use.” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
“Psoriasis patients had significantly more depressive symptoms (SMD 1.16; 95% confidence interval (CI) 0.67-1.66), and population-based studies showed that they were at least one and a half times more likely to experience depression (OR 1.57; 95% CI 1.40-1.76) and used more antidepressants than did controls (OR 4.24, 95% CI 1.53-11.76).” (opens the original PubMed page at this quote in a new tab)View highlighted excerpt for this quote
Comorbidities in moderate-to-severe psoriasis compared with matched controls
“A total of 5,492 matched pairs of moderate-to-severe PsO patients and controls were selected, with a mean age of 47.6 years and 55.5% of patients being male.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“PsA was present among 22.1% of PsO patients. Excluding PsA, the most common comorbidities in PsO patients were related to metabolic syndrome, including hyperlipidemia (33.3% vs. 27.3%, adjusted OR [aOR] = 1.3), hypertension (32.8% vs. 23.5%, aOR = 1.6), and diabetes (15.8% vs. 9.7%, aOR = 1.7). Obesity, another condition related to metabolic syndrome, was observed in 4.8% of PsO patients, compared with 2.3% of controls (aOR = 1.9). Depression and anxiety affected 9.1% and 6.3% PsO patients, respectively (aOR = 1.7 and 1.4).” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Additionally, PsO patients had an elevated risk of coronary heart disease (aOR = 1.5), cerebrovascular disease (aOR = 1.7), peripheral vascular disease (aOR = 1.6), skin cancer (aOR = 1.9) including nonmelanoma skin cancer (aOR = 2.1), and lymphoma (aOR = 22.7).” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
Cardiometabolic comorbidity rising with severity
“Individuals with psoriasis are more likely to suffer from obesity, cardiovascular disease, non-alcoholic fatty liver disease, diabetes and metabolic syndrome than the general population, with rates being especially elevated in those with more severe psoriasis.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote